JonesTrading Downgrades TRACON Pharma to Hold
Portfolio Pulse from richadhand@benzinga.com
JonesTrading analyst Soumit Roy has downgraded TRACON Pharma (NASDAQ:TCON) from Buy to Hold.
August 21, 2023 | 12:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TRACON Pharma has been downgraded from Buy to Hold by JonesTrading, which could potentially impact investor sentiment and the stock's performance.
Analyst ratings often influence investor sentiment and can impact a stock's price. A downgrade from Buy to Hold suggests that the analyst sees less upside potential, which could lead to a decrease in demand for the stock and potentially a lower stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100